We study pandemics, and the resurgence of measles is a grim sign of what's coming

"Studies have found that the cost of containing measles outbreaks is often as much as tens of thousands of dollars per case. One outbreak in Washington state in 2018-2019, which involved 72 cases-a small outbreak compared with what states are reporting now-cost US$3.2 million for the public health response, medical expenses, and productivity losses."

"How a country controls measles can be viewed as a proxy for how well it would control many other diseases. That's because the steps for stopping the spread are the same: deploying vaccines to prevent infections, detecting and isolating cases when they occur, identifying exposed contacts of infected people and making sure they stay home if they're likely to be contagious, and treating sick people safely."

"Controlling the spread of many infectious diseases depends on the public's trust in the basic components of public health. Declining MMR vaccine coverage reveals underlying challenges in public support for vaccines. Public confidence in the current Centers for Disease Control and Prevention is also eroding, according to polling from 2023 to early 2026 by the health policy organization KFF."

Measles outbreaks in the US generate significant economic burdens, with containment costs reaching tens of thousands of dollars per case. A 2018-2019 Washington state outbreak of 72 cases cost $3.2 million in public health response, medical expenses, and productivity losses. A sustained 1 percent drop in MMR vaccination coverage would cost the US billions across health care systems and the economy. Measles control serves as a proxy for managing other infectious diseases, requiring vaccines, case detection, contact isolation, and safe treatment. Declining MMR coverage reveals eroding public trust in vaccines and public health institutions. Other previously controlled diseases like whooping cough have resurged sharply in 2024-2025 compared to pre-pandemic levels, reflecting broader challenges in public confidence in disease control measures.

Read at Ars Technica